FDA Inspection 924205 — Innovative Blood Resources, a Division of New York Blood Center, Inc.

Innovative Blood Resources, a Division of New York Blood Center, Inc. — FEI 1970753

The FDA completed an inspection of Innovative Blood Resources, a Division of New York Blood Center, Inc. on April 17, 2015 in Lincoln, NE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 17, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lincoln, NE (United States)